ID: ALA5198008

Max Phase: Preclinical

Molecular Formula: C40H52N6O6

Molecular Weight: 712.89

Associated Items:

Representations

Canonical SMILES:  CC(C)[C@H](NC(=O)CCN1CCC(Oc2ccccc2Cc2ccccc2)CC1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](Cc1ccccc1)C(N)=O

Standard InChI:  InChI=1S/C40H52N6O6/c1-27(2)37(40(51)42-26-36(48)43-28(3)39(50)44-33(38(41)49)25-30-14-8-5-9-15-30)45-35(47)20-23-46-21-18-32(19-22-46)52-34-17-11-10-16-31(34)24-29-12-6-4-7-13-29/h4-17,27-28,32-33,37H,18-26H2,1-3H3,(H2,41,49)(H,42,51)(H,43,48)(H,44,50)(H,45,47)/t28-,33+,37-/m0/s1

Standard InChI Key:  YFTDYJSGMITWBN-XBZKGDHESA-N

Associated Targets(Human)

Histamine H1 receptor 7573 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 712.89Molecular Weight (Monoisotopic): 712.3948AlogP: 2.49#Rotatable Bonds: 18
Polar Surface Area: 171.96Molecular Species: BASEHBA: 7HBD: 5
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.87CX Basic pKa: 8.73CX LogP: 2.67CX LogD: 1.33
Aromatic Rings: 3Heavy Atoms: 52QED Weighted: 0.13Np Likeness Score: -0.62

References

1. Kok ZY, Stoddart LA, Mistry SJ, Mocking TAM, Vischer HF, Leurs R, Hill SJ, Mistry SN, Kellam B..  (2022)  Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H1 Receptor.,  65  (12.0): [PMID:35734860] [10.1021/acs.jmedchem.2c00125]

Source